Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes

Abstract Objective The objective of this study was to assess the association between clinically indicated liraglutide treatment and coronary artery plaque progression during 1-year follow-up in asymptomatic diabetes. Methods Patients were divided into a group receiving liraglutide (Lira+) and a grou...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Laurits Juhl Heinsen, Gokulan Pararajasingam, Thomas Rueskov Andersen, Søren Auscher, Hussam Mahmoud Sheta, Helle Precht, Kalle Brunebjerg Engdam, Jørgen Hangaard, Jess Lambrechtsen, Filip Krag Knop, Kenneth Egstrup
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2023-04-01
Sarja:	BMC Cardiovascular Disorders
Aiheet:	Type 2 diabetes mellitus Coronary atherosclerosis Glucagon-like peptide 1 receptor agonist Liraglutide Coronary computed tomography angiography
Linkit:	https://doi.org/10.1186/s12872-023-03228-5
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!